肠道治疗方案在减轻腹部外科手术患者手术后便秘的有效性
Ila Sethi1, Katherine Lam2, Caroline Sanicola3
1Division of Bariatric, Foregut, and Advanced Gastrointestinal Surgery, Department of Surgery, Stony Brook University Hospital, Stony Brook, NY, 11790, USA. ila.sethi@stonybrookmedicine.edu.
Obesity surgery
|January 29, 2024
概括
使用聚乙烯糖醇 (PEG) 的术前肠道治疗方案减少了腹手术后的严重便秘. 虽然自我报告的便秘持续存在,但PEG显著减少了急诊室的访问和住院,尽管患者的遵从性有限.
科学领域:
- 胃肠病学 胃肠病学
- 腹部外科 腹部外科
- 改善临床质量 改善临床质量
背景情况:
- 手术后便秘是减肥手术后的常见并发症,对患者的生活质量产生负面影响.
- 关于手术前干预措施在这种患者群体中控制便秘的有效性,研究有限.
研究的目的:
- 评估基于聚乙烯糖醇 (PEG) 的肠道治疗方案在减轻腹手术后便秘的频率和严重性的有效性.
- 评估PEG肠道治疗对术后便秘相关的急诊室访问和住院治疗的影响.
主要方法:
- 一项回顾性研究分析了在机构实施PEG肠道治疗方案之前和之后接受减肥手术的成年患者.
- 收集的数据包括患者报告的便秘和与便秘相关的急诊室访问或住院的30天随访.
- 统计分析,包括学生t测试,比较了PEG干预组和历史对照组之间的结果.
主要成果:
- 在探索阶段,57.14%的患者完成了PEG肠道治疗方案.
- 在实施后的一年内,只有0.85%的患者经历了与便秘相关的30天急诊室访问或住院治疗,而历史对照组的3.65% (p=0.04).
- 虽然17.9%的患者在3周的随访中报告了便秘,但PEG疗法显著降低了严重便秘的结果.
结论:
- 基于聚乙烯糖醇 (PEG) 的肠道治疗方案在减轻腹手术后严重的术后便秘方面表现有前途,减少了急诊室访问和住院治疗.
- 该方案没有消除自我报告的便秘,患者的遵守仍然是一个挑战.
- 需要进一步的策略来提高患者对肠道治疗方案的坚持,以最大限度地获得益处.
更多相关视频
相关概念视频
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
88
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
88
Inflammatory Bowel Disease V: Surgical Management
147
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
147
Drugs for Treatment of Constipation-Predominant IBS
169
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
169
Drugs Affecting GI Tract Motility: Other Laxatives
218
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
218
Drugs for Treatment of Diarrhea-Predominant IBS
175
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
175
Irritable Bowel Syndrome III: Medical and Nursing Management
208
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
208


